NEW YORK (Reuters Health) - People with severe chronic obstructive pulmonary disease (COPD), usually known as emphysema, are helped considerably when they take a combination of two inhaled drugs -- the long-acting beta-2 agonist salmeterol, which relaxes airways, and the inhaled corticosteroid fluticasone to fight inflammation, according to a new study.>>> Discuss This Story
